Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-22

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (ONESOURCE SPECIALTY PHARMA LIMITED)

View source ↗

Summary

FDA approved a supplemental application for mycophenolate mofetil submitted by Onesource Specialty Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)